Previous studies have shown that sST2 can be used to diagnose heart failure and to predict mortality after cardiac surgery for heart failure and coronary artery disease (147); however, a study has highlighted the protective role of IL-33 in patients with heart disease and reduced levels of sST2 as an inducer of IL-33 may prevent the formation of fibrosis. The gene discussed is IL33; the disease is heart disorder.